Advertisement
Home »

Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib.

May 29, 2023

ABOUT THE EXPERTS

  • Emily Brugioni

    Mission Blood + Cancer, Des Moines, IA. Electronic address: ebrugioni@missioncancer.com.

    Elizabeth Cathcart-Rake

    Mayo Clinic, Rochester, MN.

    Janie Metsker

    Saint Luke’s Hospital, Kansas City, MO.

    Elizabeth Gustafson

    Saint Luke’s Hospital, University of Missouri, Kansas City, MO.

    Lindsey Douglass

    Saint Luke’s Hospital, University of Missouri, Kansas City, MO.

    Timothy J Pluard

    Saint Luke’s Cancer Institute, University of Missouri, Kansas City, MO.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement